Catalyst Pharmaceuticals, Inc. (CPRX)
27.37
-0.31
(-1.12%)
USD |
NASDAQ |
Apr 24, 16:00
27.37
0.00 (0.00%)
After-Hours: 20:00
Catalyst Pharmaceuticals Market Cap : 3.343B for April 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ADMA Biologics, Inc. | 2.682B |
| ANI Pharmaceuticals, Inc. | 1.789B |
| Inovio Pharmaceuticals, Inc. | 79.46M |
| Indivior Pharmaceuticals, Inc. | 4.051B |
| United Therapeutics Corp. | 24.86B |
Market Cap Related Metrics
| PE Ratio | 16.25 |
| PS Ratio | 5.913 |
| PEG Ratio | 0.566 |
| Price to Book Value | 3.503 |
| Price to Free Cash Flow | 16.70 |
| Price | 27.37 |
| Earnings Yield | 6.15% |
| PEGY Ratio | 0.566 |
| Operating PE Ratio | 13.51 |
| Normalized PE Ratio | 16.30 |